Jia‐Shiuan Ju

机构：Chang Gung Memorial Hospital, Linkou Chang Gung Memorial Hospital

发表论文 21 篇 · 总被引 181 次 · h-index 8

代表论文

• Afatinib in Untreated Stage IIIB/IV Lung Adenocarcinoma with Major Uncommon Epidermal Growth Factor Receptor (EGFR) Mutations (G719X/L861Q/S768I): A Multicenter Observational Study in Taiwan (2023 · Targeted Oncology · 被引 27)
• Durvalumab as Consolidation Therapy in Post-Concurrent Chemoradiation (CCRT) in Unresectable Stage III Non-Small Cell Lung Cancer Patients: A Multicenter Observational Study (2021 · Vaccines · 被引 25)
• Brain metastasis, EGFR mutation subtype and generation of EGFR-TKI jointly influence the treatment outcome of patient with EGFR-mutant NSCLC (2023 · Scientific Reports · 被引 22)
• First- or second-generation epidermal growth factor receptor tyrosine kinase inhibitors in a large, real-world cohort of patients with non-small cell lung cancer (2021 · Therapeutic Advances in Medical Oncology · 被引 21)
• Afatinib treatment in a large real‐world cohort of nonsmall cell lung cancer patients with common and uncommon epidermal growth factor receptor mutation (2021 · International Journal of Cancer · 被引 20)
• The different overall survival between single-agent EGFR-TKI treatment and with bevacizumab in non-small cell lung cancer patients with brain metastasis (2022 · Scientific Reports · 被引 13)